Contribute Try STAT+ Today

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is rather modest. We plan to indulge our favorite hobby — promenading with the official mascot. We also plan to forage through the public library in search of a book or two and, if we have the willpower, we may also manicure the Pharmalot grounds, or maybe not. And what about you? This a fine time to enjoy the great outdoors. You could support your local economy by visiting a restaurant or two. Or you could reach out to someone special. Well, whatever you do, have a grand time. But be safe. Enjoy, and see you soon. …

Senate lawmakers are actively considering pegging the prices Medicare pays for drugs to those drug makers offer to other government programs like the veterans health program, according to STAT. The proposal, known internally as domestic reference pricing, could have a multibillion-dollar impact on drug makers, which have long opposed allowing Medicare to negotiate over drug prices. Setting prices to what the Department of Veterans Affairs pay for medicines was one of seven options outlined in a June 7 slide deck by a Senate committee.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Create a display name to comment

This name will appear with your comment